quinazolines has been researched along with zardaverine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhar, S; Fryknäs, M; Gullbo, J; Gustafsson, MG; Isaksson, A; Larsson, R; Lövborg, H; Nygren, P; Rickardson, L; Wickström, M | 1 |
| Andersson, C; Blom, K; Edqvist, PH; Fryknäs, M; Gustafsson, MG; Jarvius, M; Larsson, R; Nazir, M; Nyberg, F; Nygren, P; Senkowski, W | 1 |
2 other study(ies) available for quinazolines and zardaverine
| Article | Year |
|---|---|
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.
Topics: Carcinoma, Squamous Cell; Caspases; Combinatorial Chemistry Techniques; Drug Evaluation, Preclinical; Electronic Data Processing; Gene Expression Profiling; HeLa Cells; Humans; Models, Biological; Oligonucleotide Array Sequence Analysis; Phenotype; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Quinazolines; RNA, Messenger; Signal Transduction | 2006 |
Targeting tumor cells based on Phosphodiesterase 3A expression.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Carrier Proteins; Cell Line, Tumor; Colonic Neoplasms; Cyclic Nucleotide Phosphodiesterases, Type 3; Female; Gastrointestinal Stromal Tumors; Gene Expression; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Organ Specificity; Organoplatinum Compounds; Oxaliplatin; Phosphodiesterase Inhibitors; Pyridazines; Quinazolines; RNA, Messenger; Skin Neoplasms | 2017 |